Skip to main content
PMC home page
Protein & Cell logoLink to Protein & Cell
. 2011 May 15;2(4):333–346. doi: 10.1007/s13238-011-1033-2

Estrogen deficiency reversibly induces telomere shortening in mouse granulosa cells and ovarian aging in vivo

Sharyn Bayne 1, He Li 1,✉, Margaret E E Jones 2, Alex R Pinto 1, Michelle van Sinderen 2, Ann Drummond 2, Evan R Simpson 2, Jun-Ping Liu 1,✉
PMCID: PMC4875204  PMID: 21574023

Abstract

Estrogen is implicated as playing an important role in aging and tumorigenesis of estrogen responsive tissues; however the mechanisms underlying the mitogenic actions of estrogen are not fully understood. Here we report that estrogen deficiency in mice caused by targeted disruption of the aromatase gene results in a significant inhibition of telomerase maintenance of telomeres in mouse ovaries in a tissue-specific manner. The inhibition entails a significant shortening of telomeres and compromised proliferation in the follicular granulosa cell compartment of ovary. Gene expression analysis showed decreased levels of proto-oncogene c-Myc and the telomerase catalytic subunit, telomerase reverse transcriptase (TERT), in response to estrogen deficiency. Estrogen replacement therapy led to increases in TERT gene expression, telomerase activity, telomere length and ovarian tissue growth, thereby reinstating ovary development to normal in four weeks. Our data demonstrate for the first time that telomere maintenance is the primary mechanism mediating the mitogenic effect of estrogen on ovarian granulosa cell proliferation by upregulating the genes of c-Myc and TERT in vivo. Estrogen deficiency or over-activity may cause ovarian tissue aging or tumorigenesis, respectively, through estrogen regulation of telomere remodeling.

Keywords: estrogen, telomerase reverse transcriptase (TERT), telomeres, ovary, mice

Contributor Information

He Li, Email: he.li@mcri.edu.au.

Jun-Ping Liu, Email: jun-ping.liu@monash.edu.

References

  1. Baykal A., Thompson J.A., Xu X.C., Hahn W.C., Deavers M.T., Malpica A., Gershenson D.M., Silva E.G., Liu J. In situ human telomerase reverse transcriptase expression pattern in normal and neoplastic ovarian tissues. Oncol Rep. 2004;11:297–302. [PubMed] [Google Scholar]
  2. Bayne S., Jones M.E., Li H., Liu J.P. Potential roles for estrogen regulation of telomerase activity in aging. Ann N Y Acad Sci. 2007;1114:48–55. doi: 10.1196/annals.1396.023. [DOI] [PubMed] [Google Scholar]
  3. Bayne S., Jones M.E., Li H., Pinto A.R., Simpson E.R., Liu J. P. Estrogen deficiency leads to telomerase inhibition, telomere shortening and reduced cell proliferation in the adrenal gland of mice. Cell Res. 2008;18:1141–1150. doi: 10.1038/cr.2008.291. [DOI] [PubMed] [Google Scholar]
  4. Björnström L., Sjöberg M. Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes. Mol Endocrinol. 2005;19:833–842. doi: 10.1210/me.2004-0486. [DOI] [PubMed] [Google Scholar]
  5. Blasco M.A. Telomere length, stem cells and aging. Nat Chem Biol. 2007;3:640–649. doi: 10.1038/nchembio.2007.38. [DOI] [PubMed] [Google Scholar]
  6. Britt K.L., Drummond A.E., Dyson M., Wreford N.G., Jones M.E., Simpson E.R., Findlay J.K. The ovarian phenotype of the aromatase knockout (ArKO) mouse. J Steroid Biochem Mol Biol. 2001;79:181–185. doi: 10.1016/S0960-0760(01)00158-3. [DOI] [PubMed] [Google Scholar]
  7. Britt K.L., Findlay J.K. Regulation of the phenotype of ovarian somatic cells by estrogen. Mol Cell Endocrinol. 2003;202:11–17. doi: 10.1016/S0303-7207(03)00055-8. [DOI] [PubMed] [Google Scholar]
  8. Britt K.L., Kerr J., O’Donnell L., Jones M.E., Drummond A.E., Davis S.R., Simpson E.R., Findlay J.K. Estrogen regulates development of the somatic cell phenotype in the eutherian ovary. FASEB J. 2002;16:1389–1397. doi: 10.1096/fj.01-0992com. [DOI] [PubMed] [Google Scholar]
  9. Bullock L.P., Bardin C.W. The prosence of estrogen receptor in kidneys from normal and androgen-insensitive tfm/y mice. Endocrinology. 1975;97:1106–1111. doi: 10.1210/endo-97-5-1106. [DOI] [PubMed] [Google Scholar]
  10. Chadeneau C., Siegel P., Harley C.B., Muller W.J., Bacchetti S. Telomerase activity in normal and malignant murine tissues. Oncogene. 1995;11:893–898. [PubMed] [Google Scholar]
  11. Ciana P., Raviscioni M., Mussi P., Vegeto E., Que I., Parker M.G., Lowik C., Maggi A. In vivo imaging of transcriptionally active estrogen receptors. Nat Med. 2003;9:82–86. doi: 10.1038/nm809. [DOI] [PubMed] [Google Scholar]
  12. Filardo E., Quinn J., Pang Y., Graeber C., Shaw S., Dong J., Thomas P. Activation of the novel estrogen receptor G protein-coupled receptor 30 (GPR30) at the plasma membrane. Endocrinology. 2007;148:3236–3245. doi: 10.1210/en.2006-1605. [DOI] [PubMed] [Google Scholar]
  13. Fisher C.R., Graves K.H., Parlow A.F., Simpson E.R. Characterization of mice deficient in aromatase (ArKO) because of targeted disruption of the cyp19 gene. Proc Natl Acad Sci U S A. 1998;95:6965–6970. doi: 10.1073/pnas.95.12.6965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Flores I., Blasco M.A. A p53-dependent response limits epidermal stem cell functionality and organismal size in mice with short telomeres. PLoS One. 2009;4:e4934. doi: 10.1371/journal.pone.0004934. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Flores I., Cayuela M.L., Blasco M.A. Effects of telomerase and telomere length on epidermal stem cell behavior. Science. 2005;309:1253–1256. doi: 10.1126/science.1115025. [DOI] [PubMed] [Google Scholar]
  16. Fox E.M., Andrade J., Shupnik M.A. Novel actions of estrogen to promote proliferation: integration of cytoplasmic and nuclear pathways. Steroids. 2009;74:622–627. doi: 10.1016/j.steroids.2008.10.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Frasor J., Danes J.M., Komm B., Chang K.C., Lyttle C.R., Katzenellenbogen B.S. Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. Endocrinology. 2003;144:4562–4574. doi: 10.1210/en.2003-0567. [DOI] [PubMed] [Google Scholar]
  18. Grasselli A., Nanni S., Colussi C., Aiello A., Benvenuti V., Ragone G., Moretti F., Sacchi A., Bacchetti S., Gaetano C., et al. Estrogen receptor-alpha and endothelial nitric oxide synthase nuclear complex regulates transcription of human telomerase. Circ Res. 2008;103:34–42. doi: 10.1161/CIRCRESAHA.107.169037. [DOI] [PubMed] [Google Scholar]
  19. Greenberg R.A., O’Hagan R.C., Deng H., Xiao Q., Hann S.R., Adams R.R., Lichtsteiner S., Chin L., Morin G.B., DePinho R.A. Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation. Oncogene. 1999;18:1219–1226. doi: 10.1038/sj.onc.1202669. [DOI] [PubMed] [Google Scholar]
  20. Harrington L., Robinson M.O. Telomere dysfunction: multiple paths to the same end. Oncogene. 2002;21:592–597. doi: 10.1038/sj.onc.1205084. [DOI] [PubMed] [Google Scholar]
  21. Herrera E., Samper E., Blasco M.A. Telomere shortening in mTR-/- embryos is associated with failure to close the neural tube. EMBO J. 1999;18:1172–1181. doi: 10.1093/emboj/18.5.1172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Hirshfield A.N. Development of follicles in the mammalian ovary. Int Rev Cytol. 1991;124:43–101. doi: 10.1016/S0074-7696(08)61524-7. [DOI] [PubMed] [Google Scholar]
  23. Jin W., Chen Y., Di G.H., Miron P., Hou Y.F., Gao H., Shao Z. M. Estrogen receptor (ER) beta or p53 attenuates ERalpha-mediated transcriptional activation on the BRCA2 promoter. J Biol Chem. 2008;283:29671–29680. doi: 10.1074/jbc.M802785200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Jones M.E., Thorburn A.W., Britt K.L., Hewitt K.N., Wreford N.G., Proietto J., Oz O.K., Leury B.J., Robertson K.M., Yao S., et al. Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proc Natl Acad Sci U S A. 2000;97:12735–12740. doi: 10.1073/pnas.97.23.12735. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Kanaya T., Kyo S., Hamada K., Takakura M., Kitagawa Y., Harada H., Inoue M. Adenoviral expression of p53 represses telomerase activity through down-regulation of human telomerase reverse transcriptase transcription. Clin Cancer Res. 2000;6:1239–1247. [PubMed] [Google Scholar]
  26. Kyo S., Takakura M., Kanaya T., Zhuo W., Fujimoto K., Nishio Y., Orimo A., Inoue M. Estrogen activates telomerase. Cancer Res. 1999;59:5917–5921. [PubMed] [Google Scholar]
  27. Lacey J.V., Jr, Mink P.J., Lubin J.H., Sherman M.E., Troisi R., Hartge P., Schatzkin A., Schairer C. Menopausal hormone replacement therapy and risk of ovarian cancer. JAMA. 2002;288:334–341. doi: 10.1001/jama.288.3.334. [DOI] [PubMed] [Google Scholar]
  28. Lavranos T.C., Mathis J.M., Latham S.E., Kalionis B., Shay J.W., Rodgers R.J. Evidence for ovarian granulosa stem cells: telomerase activity and localization of the telomerase ribonucleic acid component in bovine ovarian follicles. Biol Reprod. 1999;61:358–366. doi: 10.1095/biolreprod61.2.358. [DOI] [PubMed] [Google Scholar]
  29. Lee H.W., Blasco M.A., Gottlieb G.J., Horner J.W., 2nd, Greider C. W., DePinho R.A. Essential role of mouse telomerase in highly proliferative organs. Nature. 1998;392:569–574. doi: 10.1038/33345. [DOI] [PubMed] [Google Scholar]
  30. Ling S., Zhou L., Li H., Dai A., Liu J.P., Komesaroff P.A., Sudhir K. Effects of 17beta-estradiol on growth and apoptosis in human vascular endothelial cells: influence of mechanical strain and tumor necrosis factor-alpha. Steroids. 2006;71:799–808. doi: 10.1016/j.steroids.2006.05.010. [DOI] [PubMed] [Google Scholar]
  31. Liu J.P., Chen S.M., Cong Y.S., Nicholls C., Zhou S.F., Tao Z.Z., Li H. Regulation of telomerase activity by apparently opposing elements. Ageing Res Rev. 2010;9:245–256. doi: 10.1016/j.arr.2010.03.002. [DOI] [PubMed] [Google Scholar]
  32. Liu J.P., Li H. Telomerase in the ovary. Reproduction. 2010;140:215–222. doi: 10.1530/REP-10-0008. [DOI] [PubMed] [Google Scholar]
  33. Meng Y.G., Han W.D., Zhao Y.L., Huang K., Si Y.L., Wu Z.Q., Mu Y.M. Induction of the LRP16 gene by estrogen promotes the invasive growth of Ishikawa human endometrial cancer cells through the downregulation of E-cadherin. Cell Res. 2007;17:869–880. doi: 10.1038/cr.2007.79. [DOI] [PubMed] [Google Scholar]
  34. Miller W.R., Bartlett J.M., Canney P., Verrill M. Hormonal therapy for postmenopausal breast cancer: the science of sequencing. Breast Cancer Res Treat. 2007;103:149–160. doi: 10.1007/s10549-006-9369-7. [DOI] [PubMed] [Google Scholar]
  35. Miller W.R., Larionov A., Renshaw L., Anderson T.J., White S., Hampton G., Walker J.R., Ho S., Krause A., Evans D.B., et al. Aromatase inhibitors-gene discovery. J Steroid Biochem Mol Biol. 2007;106:130–142. doi: 10.1016/j.jsbmb.2007.05.013. [DOI] [PubMed] [Google Scholar]
  36. Misiti S., Nanni S., Fontemaggi G., Cong Y.S., Wen J., Hirte H.W., Piaggio G., Sacchi A., Pontecorvi A., Bacchetti S., et al. Induction of hTERT expression and telomerase activity by estrogens in human ovary epithelium cells. [In Process Citation] Mol Cell Biol. 2000;20:3764–3771. doi: 10.1128/MCB.20.11.3764-3771.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Payne R.W., Hellbaum A.A. The effect of estrogens on the ovary of the hypophysectomized rat. Endocrinology. 1955;57:193–199. doi: 10.1210/endo-57-2-193. [DOI] [PubMed] [Google Scholar]
  38. Piontkewitz Y., Sundfeldt K., Hedin L. The expression of c-myc during follicular growth and luteal formation in the rat ovary in vivo. J Endocrinol. 1997;152:395–406. doi: 10.1677/joe.0.1520395. [DOI] [PubMed] [Google Scholar]
  39. Prowse K.R., Greider C.W. Developmental and tissue-specific regulation of mouse telomerase and telomere length. Proc Natl Acad Sci U S A. 1995;92:4818–4822. doi: 10.1073/pnas.92.11.4818. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Revankar C.M., Cimino D.F., Sklar L.A., Arterburn J.B., Prossnitz E.R. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science. 2005;307:1625–1630. doi: 10.1126/science.1106943. [DOI] [PubMed] [Google Scholar]
  41. Robker R.L., Richards J.S. Hormonal control of the cell cycle in ovarian cells: proliferation versus differentiation. Biol Reprod. 1998;59:476–482. doi: 10.1095/biolreprod59.3.476. [DOI] [PubMed] [Google Scholar]
  42. Rodgers R.J., Irving-Rodgers H.F., van Wezel I.L., Krupa M., Lavranos T.C. Dynamics of the membrana granulosa during expansion of the ovarian follicular antrum. Mol Cell Endocrinol. 2001;171:41–48. doi: 10.1016/S0303-7207(00)00430-5. [DOI] [PubMed] [Google Scholar]
  43. Rufer N., Dragowska W., Thornbury G., Roosnek E., Lansdop P.M. Telomere length dynamics in human lymphocyte subpopulations measured by flow cytometry. Nat Biotechnol. 1998;16:743–747. doi: 10.1038/nbt0898-743. [DOI] [PubMed] [Google Scholar]
  44. Russo V., Berardinelli P., Martelli A., Di Giacinto O., Nardinocchi D., Fantasia D., Barboni B. Expression of telomerase reverse transcriptase subunit (TERT) and telomere sizing in pig ovarian follicles. J Histochem Cytochem. 2006;54:443–455. doi: 10.1369/jhc.4A6603.2006. [DOI] [PubMed] [Google Scholar]
  45. Santos G.F., Scott G.K., Lee W.M.F., Liu E., Benz C. Estrogen-induced post-transcriptional modulation of c-myc proto-oncogene expression in human breast cancer cells. J Biol Chem. 1988;263:9565–9568. [PubMed] [Google Scholar]
  46. Sarkar P., Shiizaki K., Yonemoto J., Sone H. Activation of telomerase in BeWo cells by estrogen and 2,3,7,8-tetrachlorodibenzo-p-dioxin in co-operation with c-Myc. Int J Oncol. 2006;28:43–51. [PubMed] [Google Scholar]
  47. Schoeftner S., Blasco M.A. A ‘higher order’ of telomere regulation: telomere heterochromatin and telomeric RNAs. EMBO J. 2009;28:2323–2336. doi: 10.1038/emboj.2009.197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Segars J.H., Driggers P.H. Estrogen action and cytoplasmic signaling cascades. Part I: membrane-associated signaling complexes. Trends Endocrinol Metab. 2002;13:349–354. doi: 10.1016/S1043-2760(02)00633-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Shats I., Milyavsky M., Tang X., Stambolsky P., Erez N., Brosh R., Kogan I., Braunstein I., Tzukerman M., Ginsberg D., et al. p53-dependent down-regulation of telomerase is mediated by p21waf1. J Biol Chem. 2004;279:50976–50985. doi: 10.1074/jbc.M402502200. [DOI] [PubMed] [Google Scholar]
  50. Shay J.W., Bacchetti S. A survey of telomerase activity in human cancer. Eur J Cancer. 1997;33:787–791. doi: 10.1016/S0959-8049(97)00062-2. [DOI] [PubMed] [Google Scholar]
  51. Toda K., Takeda K., Okada T., Akira S., Saibara T., Kaname T., Yamamura K., Onishi S., Shizuta Y. Targeted disruption of the aromatase P450 gene (Cyp19) in mice and their ovarian and uterine responses to 17beta-oestradiol. J Endocrinol. 2001;170:99–111.. doi: 10.1677/joe.0.1700099. [DOI] [PubMed] [Google Scholar]
  52. van der Burg B., van Selm-Miltenburg A.J., de Laat S.W., van Zoelen E.J. Direct effects of estrogen on c-fos and c-myc protooncogene expression and cellular proliferation in human breast cancer cells. Mol Cell Endocrinol. 1989;64:223–228. doi: 10.1016/0303-7207(89)90149-4. [DOI] [PubMed] [Google Scholar]
  53. Yamagata Y., Nakamura Y., Umayahara K., Harada A., Takayama H., Sugino N., Kato H. Changes in telomerase activity in experimentally induced atretic follicles of immature rats. Endocr J. 2002;49:589–595. doi: 10.1507/endocrj.49.589. [DOI] [PubMed] [Google Scholar]

Articles from Protein & Cell are provided here courtesy of Oxford University Press

RESOURCES